Numinus Wellness Ownership
| NUMIF Stock | USD 0.03 0 3.45% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Numinus |
Numinus OTC Stock Ownership Analysis
The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Numinus Wellness recorded a loss per share of 0.1. The entity last dividend was issued on the 20th of May 2020. The firm had 1:2 split on the 20th of May 2020. Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. This division also offers training, facilities, and other operational resources to practitioners. Numinus Wellness is traded on OTC Exchange in the United States.The quote for Numinus Wellness is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Numinus Wellness contact Payton Nyquvest at 833 686 4687 or learn more at https://www.numinus.com.Currently Active Assets on Macroaxis
Other Information on Investing in Numinus OTC Stock
Numinus Wellness financial ratios help investors to determine whether Numinus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Numinus with respect to the benefits of owning Numinus Wellness security.